Aurinia Pharmaceuticals Inc Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 84.05. In total, the insiders bought 7 892 639 and sold 621 709 AUPH shares in the last 100 trades.

Insider Power

(Last 100 transactions)
84.05
Buy 7 892 639 Shares
Sell 621 709 Shares

Historical Insider Trades

Date Type Action Person Amount
Nov 21, 2024 Common Shares Buy Smith Karen L. 12 135
Nov 21, 2024 Director Stock Option (right to buy) Buy Smith Karen L. 18 641
Nov 21, 2024 Common Shares Buy Leversage Jill 12 135
Nov 21, 2024 Director Stock Option (right to buy) Buy Leversage Jill 18 641
Nov 21, 2024 Director Stock Option (right to buy) Buy Johnson Craig A 31 688
Nov 21, 2024 Common Shares Buy Johnson Craig A 20 631
Nov 21, 2024 Common Shares Buy Bailey Jeffrey Allen 12 135
Nov 21, 2024 Director Stock Option (right to buy) Buy Bailey Jeffrey Allen 18 641
Nov 21, 2024 Common Shares Buy Jayne David R.w. 12 135
Nov 21, 2024 Director Stock Option (right to buy) Buy Jayne David R.w. 18 641
Nov 11, 2024 Common Stock Sell Bailey Jeffrey Allen 4 557
Nov 11, 2024 Common Stock Sell Smith Karen L. 5 241
Nov 08, 2024 Common Stock Buy Bailey Jeffrey Allen 17 913
Nov 08, 2024 Restricted Stock Units Sell Bailey Jeffrey Allen 17 913
Nov 08, 2024 Common Stock Buy Smith Karen L. 17 913
Nov 08, 2024 Restricted Stock Units Sell Smith Karen L. 17 913
Nov 07, 2024 Common Stock Buy Keenan Greg 0
Nov 07, 2024 Stock Option (right to buy) Buy Keenan Greg 81 990
Nov 07, 2024 Buy Johnson Craig A 0
Sep 12, 2024 Common Shares Buy Tang Kevin 0
Sep 12, 2024 Short Put Options (potential obligation to buy) Buy Tang Kevin 3 000 000
Sep 09, 2024 Buy Mackay-dunn R. Hector 0
Aug 06, 2024 Common Stock Sell Habig Scott Michael 18 249
May 21, 2024 Common Stock Sell Balakrishnan Brinda 520
May 21, 2024 Common Stock Sell Billen Daniel 5 252
Click to get the best stock tips daily for free!
ABOUT AURINIA PHARMACEUTICALS INC
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada....
GOLDEN STAR
Ticker Change Signal Date
NYT
$54.61
2.98% Dec 04
V
VCSH
$78.49
0.140% Dec 04
V
VGSH
$58.30
0.103% Dec 04
S
SLQD
$49.95
0.160% Dec 04
I
ISTB
$48.00
0.208% Dec 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE